Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
ESMO 2024: Latest updates in mRCC
Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane...
ESMO 2024: Latest updates in mRCC ( Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane Oudard )
15 Sep 2024
Understanding the use of PARPi combinations to treat patients with mCRPC
Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof...
Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )
15 Sep 2024
Enzalutamide treatment boosted by Radium-223 in mCRPC
Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona...
Enzalutamide treatment boosted by Radium-223 in mCRPC ( Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )
15 Sep 2024
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...
Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Nivolumab plus ipilimumab improves efficacy versus standard of care in non...
Prof Lothar Bergmann - University Hospital Frankurt, Frankfurt am Main, Germany
Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell carcinomas ( Prof Lothar Bergmann - University Hospital Frankurt, Frankfurt am Main, Germany )
14 Sep 2024
Repeat immune checkpoint inhibitor therapy not recommended for aRCC
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Repeat immune checkpoint inhibitor therapy not recommended for aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024
Assessment of suicide risk in cancer patients
Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India
Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )
10 Sep 2024
Association of adult attachment with delays in accessing specialist care in...
Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India
Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )
7 Sep 2024
Cancer journeys: Research from India
Ms. Soumita Ghose - Tata Medical Center, Kolkata
Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )
7 Sep 2024
Depression in cancer
Ms. Bidisha Samanta - Rocket Health, Kolkata, India
Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )
7 Sep 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation